» Articles » PMID: 15984895

Behavioural Manifestations of Anabolic Steroid Use

Overview
Journal CNS Drugs
Specialties Neurology
Pharmacology
Date 2005 Jun 30
PMID 15984895
Citations 34
Authors
Affiliations
Soon will be listed here.
Abstract

The use of anabolic androgenic steroids (AAS) for gains in strength and muscle mass is relatively common among certain subpopulations, including athletes, bodybuilders, adolescents and young adults. Adverse physical effects associated with steroid abuse are well documented, but more recently, increased attention has been given to the adverse psychiatric effects of these compounds. Steroids may be used in oral, 17alpha-alkylated, or intramuscular, 17beta-esterified, preparations. Commonly, steroid users employ these agents at levels 10- to 100-fold in excess of therapeutic doses and use multiple steroids simultaneously, a practice known as 'stacking'. Significant psychiatric symptoms including aggression and violence, mania, and less frequently psychosis and suicide have been associated with steroid abuse. Long-term steroid abusers may develop symptoms of dependence and withdrawal on discontinuation of AAS. Treatment of AAS abusers should address both acute physical and behavioural symptoms as well as long-term abstinence and recovery. To date, limited information is available regarding specific pharmacological treatments for individuals recovering from steroid abuse. This paper reviews the published literature concerning the recognition and treatment of behavioural manifestations of AAS abuse.

Citing Articles

Sex differences in opioid receptor mediated effects: Role of androgens.

Sharp J, Pearson T, Smith M Neurosci Biobehav Rev. 2022; 134:104522.

PMID: 34995646 PMC: 8872632. DOI: 10.1016/j.neubiorev.2022.104522.


Anabolic androgenic steroids used as performance and image enhancing drugs in professional and amateur athletes: Toxicological and psychopathological findings.

Piacentino D, Sani G, Kotzalidis G, Cappelletti S, Longo L, Rizzato S Hum Psychopharmacol. 2021; 37(1):e2815.

PMID: 34528289 PMC: 8727496. DOI: 10.1002/hup.2815.


Severe Cardiac and Metabolic Pathology Induced by Steroid Abuse in a Young Individual.

Tirla A, Vesa C, Cavalu S Diagnostics (Basel). 2021; 11(8).

PMID: 34441248 PMC: 8394374. DOI: 10.3390/diagnostics11081313.


Aggression and Psychological Distress in Male and Female Anabolic-Androgenic Steroid Users: A Multigroup Latent Class Analysis.

Chegeni R, Notelaers G, Pallesen S, Sagoe D Front Psychiatry. 2021; 12:629428.

PMID: 34149470 PMC: 8211877. DOI: 10.3389/fpsyt.2021.629428.


Review Article: Anabolic-Androgenic Steroids, Violence, and Crime: Two Cases and Literature Review.

Pope Jr H, Kanayama G, Hudson J, Kaufman M Am J Addict. 2021; 30(5):423-432.

PMID: 33870584 PMC: 8995103. DOI: 10.1111/ajad.13157.


References
1.
Pope Jr H, Katz D, Hudson J . Anorexia nervosa and "reverse anorexia" among 108 male bodybuilders. Compr Psychiatry. 1993; 34(6):406-9. DOI: 10.1016/0010-440x(93)90066-d. View

2.
Dickerman R, SCHALLER F, Prather I, McConathy W . Sudden cardiac death in a 20-year-old bodybuilder using anabolic steroids. Cardiology. 1995; 86(2):172-3. DOI: 10.1159/000176867. View

3.
Brower K, Blow F, Eliopulos G, Beresford T . Anabolic androgenic steroids and suicide. Am J Psychiatry. 1989; 146(8):1075. DOI: 10.1176/ajp.146.8.1075a. View

4.
Hamilton M . Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967; 6(4):278-96. DOI: 10.1111/j.2044-8260.1967.tb00530.x. View

5.
Alen M, Reinila M, Vihko R . Response of serum hormones to androgen administration in power athletes. Med Sci Sports Exerc. 1985; 17(3):354-9. View